Mary Mosher

Array ( [id] => 8749301 [patent_doc_number] => 08415132 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-09 [patent_title] => 'Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines' [patent_app_type] => utility [patent_app_number] => 13/214836 [patent_app_country] => US [patent_app_date] => 2011-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 18264 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13214836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7656845 [patent_doc_number] => 20110306114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'PURIFICATION OF VACCINIA VIRUSES USING HYDROPHOBIC INTERACTION CHROMATOGRAPHY' [patent_app_type] => utility [patent_app_number] => 13/214979 [patent_app_country] => US [patent_app_date] => 2011-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18183 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306114.pdf [firstpage_image] =>[orig_patent_app_number] => 13214979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8041375 [patent_doc_number] => 20120070429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'HUMANIZED ANTIBODIES AGAINST WEST NILE VIRUS AND THERAPEUTIC AND PROPHYLACTIC USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/214975 [patent_app_country] => US [patent_app_date] => 2011-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 42814 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20120070429.pdf [firstpage_image] =>[orig_patent_app_number] => 13214975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8359817 [patent_doc_number] => 20120214976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'Scalable Process for Protein Purification' [patent_app_type] => utility [patent_app_number] => 13/214825 [patent_app_country] => US [patent_app_date] => 2011-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18155 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13214825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9626008 [patent_doc_number] => 08795683 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-05 [patent_title] => 'Vaccine formulations and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/178198 [patent_app_country] => US [patent_app_date] => 2011-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 5421 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13178198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8251917 [patent_doc_number] => 20120156237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'Novel Antitoxin and Vaccine Platform Based on Nodavirus VLPS' [patent_app_type] => utility [patent_app_number] => 13/167627 [patent_app_country] => US [patent_app_date] => 2011-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 26712 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20120156237.pdf [firstpage_image] =>[orig_patent_app_number] => 13167627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7710928 [patent_doc_number] => 20120003627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'Portable Fluorescence Reader Device' [patent_app_type] => utility [patent_app_number] => 13/167223 [patent_app_country] => US [patent_app_date] => 2011-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 38800 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13167223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9888763 [patent_doc_number] => 08975016 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-10 [patent_title] => 'Methods for direct fluorescent antibody virus detection in liquids' [patent_app_type] => utility [patent_app_number] => 13/166228 [patent_app_country] => US [patent_app_date] => 2011-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 30272 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13166228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8515887 [patent_doc_number] => 20120315295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-13 [patent_title] => 'Development of a Marker Foot and Mouth Disease Virus Vaccine Candidate That is Attenuated in the Natural Host' [patent_app_type] => utility [patent_app_number] => 13/157097 [patent_app_country] => US [patent_app_date] => 2011-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21697 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13157097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7807182 [patent_doc_number] => 20120058136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'NON-SPLICING VARIANTS OF gp350/220' [patent_app_type] => utility [patent_app_number] => 13/116206 [patent_app_country] => US [patent_app_date] => 2011-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10179 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058136.pdf [firstpage_image] =>[orig_patent_app_number] => 13116206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9843989 [patent_doc_number] => 08945904 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-03 [patent_title] => 'Influenza virus reassortment' [patent_app_type] => utility [patent_app_number] => 13/699301 [patent_app_country] => US [patent_app_date] => 2011-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 14696 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8054055 [patent_doc_number] => 20120076758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'ANTIBODIES AGAINST WEST NILE VIRUS AND THERAPEUTIC AND PROPHYLACTIC USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/097337 [patent_app_country] => US [patent_app_date] => 2011-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 49505 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20120076758.pdf [firstpage_image] =>[orig_patent_app_number] => 13097337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6062255 [patent_doc_number] => 20110200628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'Chimeric Proteins that Induce Effects Directed Against Viruses' [patent_app_type] => utility [patent_app_number] => 13/094287 [patent_app_country] => US [patent_app_date] => 2011-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20820 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200628.pdf [firstpage_image] =>[orig_patent_app_number] => 13094287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6164956 [patent_doc_number] => 20110195088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'Porcine Reproductive and Respiratory Syndrome Isolates and Methods of Use' [patent_app_type] => utility [patent_app_number] => 13/085692 [patent_app_country] => US [patent_app_date] => 2011-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9679 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195088.pdf [firstpage_image] =>[orig_patent_app_number] => 13085692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9589143 [patent_doc_number] => 08778684 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-15 [patent_title] => 'Herpes simplex virus complex' [patent_app_type] => utility [patent_app_number] => 13/086215 [patent_app_country] => US [patent_app_date] => 2011-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5091 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13086215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8138603 [patent_doc_number] => 20120093853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'Simian Adenovirus Vectors and Methods of Use' [patent_app_type] => utility [patent_app_number] => 13/084596 [patent_app_country] => US [patent_app_date] => 2011-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 38190 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20120093853.pdf [firstpage_image] =>[orig_patent_app_number] => 13084596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487530 [patent_doc_number] => 20110236416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'FOOT AND MOUTH DISEASE VIRUS RECOMBINANT VACCINES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/046255 [patent_app_country] => US [patent_app_date] => 2011-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 25008 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236416.pdf [firstpage_image] =>[orig_patent_app_number] => 13046255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936034 [patent_doc_number] => 20110212131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'METHOD FOR ENHANCING AN IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 13/046038 [patent_app_country] => US [patent_app_date] => 2011-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6277 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212131.pdf [firstpage_image] =>[orig_patent_app_number] => 13046038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586394 [patent_doc_number] => 20110280904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'Generation of virus-like particles and use as panfilovirus vaccine' [patent_app_type] => utility [patent_app_number] => 12/932195 [patent_app_country] => US [patent_app_date] => 2011-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 24116 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280904.pdf [firstpage_image] =>[orig_patent_app_number] => 12932195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8509587 [patent_doc_number] => 20120308995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-06 [patent_title] => 'VACCINIA VIRUS MUTANTS CONTAINING THE MAJOR GENOMIC DELETIONS OF MVA' [patent_app_type] => utility [patent_app_number] => 13/575773 [patent_app_country] => US [patent_app_date] => 2011-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 19271 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575773 [rel_patent_id] =>[rel_patent_doc_number] =>)